Search - Université de Rennes Access content directly

Filter your results

20 Results
Author: personID (integer) : 764350

Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

Lucas Guillo , Pierre Delanaye , Martin Flamant , Lucile Figueres , Sabine Karam et al.
Digestive and Liver Disease, 2022, 54 (3), pp.309-315. ⟨10.1016/j.dld.2021.11.008⟩
Journal articles hal-03519669v1

Determinants of IBD-related disability: a cross-sectional survey from the GETAID.

Jenny Tannoury , Maria Nachury , Carole Martins , Melanie Serrero , Jerome Filippi et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (10), pp.1098-1107. ⟨10.1111/apt.16353⟩
Journal articles hal-03216615v1

Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.

Guillaume Bouguen , Jean-Baptiste Chevaux , Laurent Peyrin-Biroulet
World Journal of Gastroenterology, 2011, 17 (5), pp.547-56. ⟨10.3748/wjg.v17.i5.547⟩
Journal articles hal-01134847v1

Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease.

Guillaume Bouguen , David Laharie , Stéphane Nancey , Xavier Hebuterne , Bernard Flourie et al.
Inflammatory Bowel Diseases, 2015, 21 (5), pp.1047-1053. ⟨10.1097/MIB.0000000000000359⟩
Journal articles hal-01138534v1
Image document

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Loriane Lair-Mehiri , Carmen Stefanescu , Thibaut Vaysse , David Laharie , Xavier Roblin et al.
Digestive and Liver Disease, 2020, 52 (3), pp.268-273. ⟨10.1016/j.dld.2019.10.003⟩
Journal articles hal-03287300v1

Tu1940 Patients' Point of View Regarding Acceptability and Usefulness of Inflammatory Bowel Diseases Monitoring Tools: Results From a Nationwide Multicenter Study (the ACCEPT Study)

Anthony Buisson , Florent Gonzalez , Florian Poullenot , Stephane Nancey , Elisa Sollelis et al.
Gastroenterology, 2016, 150 (4), pp.S984. ⟨10.1016/S0016-5085(16)33333-9⟩
Journal articles hal-01335055v1
Image document

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease.

Guillaume Bouguen , Barrett G. Levesque , Brian G. Feagan , Arthur Kavanaugh , Laurent Peyrin-Biroulet et al.
Clinical Gastroenterology and Hepatology, 2013, 13 (6), pp.1042-1050.e2. ⟨10.1016/j.cgh.2013.09.006⟩
Journal articles hal-00878688v1

Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study

Mathurin Fumery , Jerome Filippi , Vered Abitbol , Amelie Biron , David Laharie et al.
Alimentary Pharmacology and Therapeuthics, 2021, 54 (7), pp.944-951. ⟨10.1111/apt.16544⟩
Journal articles hal-03336375v1
Image document

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

Aurelien Amiot , Jerome Filippi , Vered Abitbol , Guillaume Cadiot , David Laharie et al.
Alimentary Pharmacology and Therapeutics, 2020, 51 (11), pp.1039-1046. ⟨10.1111/apt.15717⟩
Journal articles hal-02798010v1

Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study

Marianne Hupe , Pauline Riviere , Stephane Nancey , Xavier Roblin , Romain Altwegg et al.
Alimentary Pharmacology and Therapeutics, 2020, 51 (9), pp.852-860. ⟨10.1111/apt.15680⟩
Journal articles hal-02562228v1
Image document

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

Guillaume Pineton de Chambrun , Aurélien Amiot , Guillaume Bouguen , Stéphanie Viennot , Romain Altwegg et al.
Clinical Gastroenterology and Hepatology, 2020, 18 (3), pp.620-627.e1. ⟨10.1016/j.cgh.2019.05.060⟩
Journal articles hal-02179668v1
Image document

Prevalence of anti-TNF contraindications in Crohn’s disease: A cross-sectional survey from the GETAID

Aurelien Amiot , Philippe Seksik , Jean-Marie Reimund , Maria Nachury , Romain Altwegg et al.
Digestive and Liver Disease, 2022, 54 (10), pp.1350-1357. ⟨10.1016/j.dld.2022.04.011⟩
Journal articles hal-03690498v1
Image document

Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study

Laurent Peyrin-Biroulet , Guillaume Bouguen , David Laharie , Gauthier Pellet , Guillaume Savoye et al.
Digestive Diseases and Sciences, 2022, 67 (12), pp.5637-5646. ⟨10.1007/s10620-022-07474-z⟩
Journal articles hal-03657045v1

Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease.

Anthony Lopez , Morgane Mounier , Anne-Marie Bouvier , Fabrice Carrat , Marc Maynadié et al.
Clinical Gastroenterology and Hepatology, 2014, 12 (8), pp.1324-1329. ⟨10.1016/j.cgh.2014.02.026⟩
Journal articles hal-00955200v1
Image document

Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study

Anne-Laure Mallet , Guillaume Bouguen , Guillaume Conroy , Xavier Roblin , Jean-Bernard Delobel et al.
Digestive and Liver Disease, 2017, 49 (3), pp.280-285. ⟨10.1016/j.dld.2016.12.001⟩
Journal articles hal-01483854v1

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients with Inflammatory Bowel Disease

Aurelien Amiot , Jean-Charles Grimaud , Laurent Peyrin-Biroulet , Jérome Filippi , Benjamin Pariente et al.
Clinical Gastroenterology and Hepatology, 2016, 14 (11), pp.1593-1601.e2. ⟨10.1016/j.cgh.2016.02.016⟩
Journal articles hal-01278611v1
Image document

Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study

Antoine Martin , Maria Nachury , Laurent Peyrin-Biroulet , Yoram Bouhnik , Stephane Nancey et al.
Journal of Crohn's & Colitis, 2020, 14 (7), pp.896-903. ⟨10.1093/ecco-jcc/jjaa005⟩
Journal articles hal-02442530v1
Image document

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents

Pauline Wils , Yoram Bouhnik , Pierre Michetti , Bernard Flourie , Hedia Brixi et al.
Clinical Gastroenterology and Hepatology, 2016, 14 (2), pp.242-250.e2. ⟨10.1016/j.cgh.2015.09.018⟩
Journal articles hal-01214012v1

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

Doriane Broussard , Pauline Riviere , Joelle Bonnet , Ginette Fotsing , Aurelien Amiot et al.
Alimentary Pharmacology and Therapeuthics, 2021, 53 (3), pp.400-409. ⟨10.1111/apt.16176⟩
Journal articles hal-03228852v1

Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients

Constance Chapuis-Biron , Anne Bourrier , Maria Nachury , Stephane Nancey , Yoram Bouhnik et al.
Alimentary Pharmacology and Therapeuthics, 2020, 51 (7), pp.719-727. ⟨10.1111/apt.15665⟩
Journal articles hal-03228900v1